Evolving Evidence Reviews

Evolving Evidence Reviews are designed to help clients develop policies and manage prior authorizations. Evolving Evidence Reviews are useful when a technology moves beyond emerging but the literature is not mature enough for a full Health Technology Assessment. Evolving Evidence Reviews provide a full-text appraisal of clinical studies, systematic reviews, and clinical practice guidelines as they relate to a specific health technology. Evolving Evidence Reviews provide Levels of Support indicated by these types of evidence. They also provide information on regulatory status, payer policies, and Hayes Insights.

MindMotion GO (MindMaze) for Stroke Telerehabilitation

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of MindMotion GO (MindMaze) for stroke telerehabilitation to improve motor function.

Durysta (Allergan) Implant for Treatment of Glaucoma

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Durysta implant for reducing intraocular pressure (IOP) in glaucoma patients.

Intravascular Lithotripsy for Calcified Peripheral Arterial Lesions

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of intravascular lithotripsy (IVL) for treatment of calcified arteries in patients with peripheral artery disease (PAD).

Subchondral Calcium Phosphate Injections for Knee Bone Marrow Lesions

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of subchondral calcium phosphate (SCP) injections for the treatment of pain and function impairment due to bone marrow lesions (BMLs) associated with knee osteoarthritis (KOA) and/or insufficiency fractures.

Somryst (Pear Therapeutics Inc.) for Treatment of Insomnia

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Somryst (Pear Therapeutics Inc.) for the treatment of chronic insomnia in adults.